Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01014195 · ClinicalTrials.gov registry record
Risk of Psychopathology and Neurocognitive Impairment in Leukemia Survivors
A clinical trial, sponsored by St. Jude Children's Research Hospital.
- Completed
- Registry status
- 237
- Enrollment target
NCT01014195 is a clinical trial that has completed, run by St. Jude Children's Research Hospital. The registered enrollment target is 237 participants.
The verdict
NCT01014195 has completed, sponsored by St. Jude Children's Research Hospital.
- COMPLETED
- Registry status
- 237 participants
- Enrollment target
Study Summary
1. This study will evaluate the association between changes in basic cognitive and behavioral functioning by the end of chemotherapy treatment, and the later development of higher order executive functions in pediatric acute lymphoblastic leukemia (ALL). 2. The association between acute treatment-related changes in brain integrity and subsequent brain maturation in long-term survivors of pediatric ALL will be evaluated. 3. The association between patterns of behavioral and executive dysfunction and brain maturation in long-term survivors of pediatric ALL will be examined. 4. The association between genetic polymorphisms in key enzyme pathways and higher order brain development in long-term survivors of pediatric ALL will be explored. 5. The associations between biologic and behavioral indices of fatigue/sleep and higher order brain development in long-term survivors of pediatric ALL will be explored.
Interventions
- OTHER Neurocognitive and behavioral evaluation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 237 participants |
| Start Date | 2010-01 |
| Est. Completion | 2014-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01014195
The ClinicalTrials.gov registry entry for NCT01014195 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 237 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Jude Children's Research Hospital, which has 410 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Neurocognitive and behavioral evaluation is the first listed.
NCT01014195 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01014195 about?
NCT01014195 is a clinical study titled "Risk of Psychopathology and Neurocognitive Impairment in Leukemia Survivors". 1. This study will evaluate the association between changes in basic cognitive and behavioral functioning by the end of chemotherapy treatment, and the later development of higher order executive functions in pediatric acute lymphoblastic leukemia (ALL). 2. The association between acute treatment-re...
What is the current status of trial NCT01014195?
This trial is currently completed. The enrollment target is 237 participants. The study started on 2010-01. Estimated completion is 2014-10.
What interventions are being tested in trial NCT01014195?
The interventions under investigation include: Neurocognitive and behavioral evaluation (OTHER).
Who is sponsoring clinical trial NCT01014195?
This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.